ec_id stringlengths 8 8 | translator_id stringlengths 10 29 | drugbank_id stringlengths 7 12 ⌀ | drug_name stringlengths 5 40 | target stringlengths 13 13 | disease_name stringlengths 4 144 | on_label bool 2
classes | off_label bool 2
classes | __index_level_0__ int64 10 4.21k |
|---|---|---|---|---|---|---|---|---|
EC:00230 | CHEBI:3176 | DB01194 | Brinzolamide | MONDO:0006875 | ocular hypertension | true | false | 556 |
EC:00230 | CHEBI:3176 | DB01194 | Brinzolamide | MONDO:0005338 | open-angle glaucoma | true | false | 559 |
EC:00231 | CHEBI:133013 | DB05541 | Brivaracetam | MONDO:0005384 | focal epilepsy | true | false | 560 |
EC:00232 | UNII:6ZA31Y954Z | DB11776 | Brodalumab | MONDO:0005083 | psoriasis | true | false | 561 |
EC:00233 | UNII:XSZ53G39H5 | DB14864 | Brolucizumab | MONDO:0005417 | wet macular degeneration | true | false | 562 |
EC:00233 | UNII:XSZ53G39H5 | DB14864 | Brolucizumab | MONDO:0004728 | diabetic macular edema | true | false | 563 |
EC:00235 | CHEBI:3181 | DB01200 | Bromocriptine | MONDO:0019933 | acromegaly | true | false | 564 |
EC:00235 | CHEBI:3181 | DB01200 | Bromocriptine | MONDO:0005148 | type 2 diabetes mellitus | true | false | 565 |
EC:00235 | CHEBI:3181 | DB01200 | Bromocriptine | MONDO:0019790 | neuroleptic malignant syndrome | false | true | 566 |
EC:00235 | CHEBI:3181 | DB01200 | Bromocriptine | MONDO:0005180 | Parkinson disease | true | false | 567 |
EC:00235 | CHEBI:3181 | DB01200 | Bromocriptine | MONDO:0003430 | prolactin producing pituitary tumor | true | false | 568 |
EC:00235 | CHEBI:3181 | DB01200 | Bromocriptine | MONDO:0010911 | prolactin-producing pituitary gland adenoma | true | false | 569 |
EC:00235 | CHEBI:3181 | DB01200 | Bromocriptine | MONDO:0005804 | hyperprolactinemia | true | false | 570 |
EC:00236 | CHEBI:3183 | DB00835 | Brompheniramine | MONDO:0011786 | allergic rhinitis | true | false | 572 |
EC:00237 | CHEBI:3207 | DB01222 | Budesonide | MONDO:0004979 | asthma | true | false | 573 |
EC:00237 | CHEBI:3207 | DB01222 | Budesonide | MONDO:0005002 | chronic obstructive pulmonary disease | true | false | 575 |
EC:00237 | CHEBI:3207 | DB01222 | Budesonide | MONDO:0005011 | Crohn disease | true | false | 578 |
EC:00237 | CHEBI:3207 | DB01222 | Budesonide | MONDO:0005361 | eosinophilic esophagitis | true | false | 579 |
EC:00237 | CHEBI:3207 | DB01222 | Budesonide | MONDO:0005342 | IgA Nephropathy | true | false | 581 |
EC:00237 | CHEBI:3207 | DB01222 | Budesonide | MONDO:0000702 | microscopic colitis | true | false | 582 |
EC:00241 | CHEBI:3216 | DB00921 | Buprenorphine | MONDO:0001225 | Opioid abuse | true | false | 583 |
EC:00241 | CHEBI:3216 | DB00921 | Buprenorphine | MONDO:0005530 | Opioid dependence | true | false | 585 |
EC:00242 | CHEBI:3219 | DB01156 | Bupropion | MONDO:0002009 | major depressive disorder | true | false | 586 |
EC:00242 | CHEBI:3219 | DB01156 | Bupropion | MONDO:0000694 | seasonal affective disorder | true | false | 587 |
EC:00242 | CHEBI:3219 | DB01156 | Bupropion | MONDO:0008575 | nicotine dependence | true | false | 588 |
EC:00243 | UNII:G9WJT6RD29 | DB14012 | Burosumab | MONDO:0018124 | oncogenic osteomalacia | true | false | 591 |
EC:00243 | UNII:G9WJT6RD29 | DB14012 | Burosumab | MONDO:0010619 | X-linked dominant hypophosphatemic rickets | true | false | 592 |
EC:00244 | CHEBI:135907 | DB06719 | Buserelin | MONDO:0005133 | endometriosis | true | false | 593 |
EC:00245 | CHEBI:3223 | DB00490 | Buspirone | MONDO:0001942 | generalized anxiety disorder | true | false | 594 |
EC:00245 | CHEBI:3223 | DB00490 | Buspirone | MONDO:0001247 | social phobia | false | true | 595 |
EC:00245 | CHEBI:3223 | DB00490 | Buspirone | MONDO:0002009 | major depressive disorder | false | true | 596 |
EC:00246 | CHEBI:28901 | DB01008 | Busulfan | MONDO:0011996 | chronic myelogenous leukemia, BCR-ABL1 positive | true | false | 597 |
EC:00246 | CHEBI:28901 | DB01008 | Busulfan | MONDO:0005029 | essential thrombocythemia | false | true | 600 |
EC:00246 | CHEBI:28901 | DB01008 | Busulfan | MONDO:0009692 | myelofibrosis | false | true | 601 |
EC:00246 | CHEBI:28901 | DB01008 | Busulfan | MONDO:0009891 | acquired polycythemia vera | false | true | 602 |
EC:00395 | UNII:5QS67N4551 | DB09228 | C1 Inhibitor | MONDO:0019623 | hereditary angioedema | true | false | 604 |
EC:00395 | UNII:5QS67N4551 | DB09228 | C1 Inhibitor | MONDO:0033946 | hereditary angioedema with C1Inh deficiency | true | false | 605 |
EC:00395 | UNII:5QS67N4551 | DB09228 | C1 Inhibitor | MONDO:0007361 | C1 inhibitor deficiency | true | false | 606 |
EC:00395 | UNII:5QS67N4551 | DB09228 | C1 Inhibitor | MONDO:0015053 | hereditary angioedema type 1 | true | false | 607 |
EC:00395 | UNII:5QS67N4551 | DB09228 | C1 Inhibitor | MONDO:0015054 | hereditary angioedema type 2 | true | false | 608 |
EC:00250 | CHEBI:63584 | DB06772 | Cabazitaxel | MONDO:0004956 | metastatic prostate carcinoma | true | false | 609 |
EC:00251 | CHEBI:3286 | DB00248 | Cabergoline | MONDO:0019933 | acromegaly | false | true | 610 |
EC:00251 | CHEBI:3286 | DB00248 | Cabergoline | MONDO:0009050 | Cushing disease due to pituitary adenoma | false | true | 611 |
EC:00251 | CHEBI:3286 | DB00248 | Cabergoline | MONDO:0005804 | hyperprolactinemia | true | false | 612 |
EC:00251 | CHEBI:3286 | DB00248 | Cabergoline | MONDO:0023209 | galactorrhoea-hyperprolactinaemia | true | false | 613 |
EC:00251 | CHEBI:3286 | DB00248 | Cabergoline | MONDO:0003430 | prolactin producing pituitary tumor | true | false | 614 |
EC:00251 | CHEBI:3286 | DB00248 | Cabergoline | MONDO:0010911 | prolactin-producing pituitary gland adenoma | true | false | 615 |
EC:00251 | CHEBI:3286 | DB00248 | Cabergoline | MONDO:0011972 | ovarian hyperstimulation syndrome | false | true | 616 |
EC:00253 | CHEBI:72317 | DB08875 | Cabozantinib | MONDO:0007256 | Hepatocellular carcinoma | true | false | 617 |
EC:00253 | CHEBI:72317 | DB08875 | Cabozantinib | MONDO:0005086 | renal cell carcinoma | true | false | 618 |
EC:00253 | CHEBI:72317 | DB08875 | Cabozantinib | MONDO:0015447 | differentiated thyroid carcinoma | true | false | 625 |
EC:00253 | CHEBI:72317 | DB08875 | Cabozantinib | MONDO:0015277 | medullary thyroid gland carcinoma | true | false | 628 |
EC:00254 | CHEBI:27732 | DB00201 | Caffeine | MONDO:0020567 | apnea of prematurity | true | false | 630 |
EC:00255 | UNII:T9FVH03HMZ | DB14730 | Calaspargase pegol | MONDO:0004967 | acute lymphoblastic leukemia | true | false | 638 |
EC:00334 | UNII:1C6V77QF41 | DB00169 | Calcifediol | MONDO:0001530 | secondary hyperparathyroidism of renal origin | true | false | 640 |
EC:00334 | UNII:1C6V77QF41 | DB00169 | Calcifediol | MONDO:0006964 | secondary hyperparathyroidism | true | false | 641 |
EC:00334 | UNII:1C6V77QF41 | DB00169 | Calcifediol | MONDO:0006946 | renal osteodystrophy | true | false | 642 |
EC:00334 | UNII:1C6V77QF41 | DB00169 | Calcipotriene | MONDO:0005083 | psoriasis | true | false | 643 |
EC:00256 | CHEBI:3306 | DB00017 | Calcitonin | MONDO:0043455 | humoral hypercalcemia of malignancy | true | false | 644 |
EC:00256 | CHEBI:3306 | DB00017 | Calcitonin | MONDO:0001566 | hypercalcemia disease | true | false | 659 |
EC:00256 | CHEBI:3306 | DB00017 | Calcitonin | MONDO:0008159 | postmenopausal osteoporosis | true | false | 661 |
EC:00256 | CHEBI:3306 | DB00017 | Calcitonin | MONDO:0005382 | bone Paget disease | true | false | 662 |
EC:00256 | CHEBI:3306 | DB00017 | Calcitonin | MONDO:0005309 | spinal fracture | false | true | 663 |
EC:00334 | UNII:1C6V77QF41 | DB00169 | Calcitriol | MONDO:0019992 | pseudohypoparathyroidism | true | false | 664 |
EC:00334 | UNII:1C6V77QF41 | DB00169 | Calcitriol | MONDO:0010619 | X-linked dominant hypophosphatemic rickets | false | true | 666 |
EC:00334 | UNII:1C6V77QF41 | DB00169 | Calcitriol | MONDO:0009924 | vitamin D-dependent rickets, type 1 | false | true | 672 |
EC:00260 | UNII:Q4K217VGA9 | DB06415 | Calfactant | MONDO:0700081 | Neonatal respiratory distress syndrome | true | false | 678 |
EC:00261 | CHEBI:73274 | DB08907 | Canagliflozin | MONDO:0005148 | type 2 diabetes mellitus | true | false | 679 |
EC:00262 | UNII:37CQ2C7X93 | DB06168 | Canakinumab | MONDO:0016168 | cryopyrin-associated periodic syndrome | true | false | 684 |
EC:00262 | UNII:37CQ2C7X93 | DB06168 | Canakinumab | MONDO:0018088 | familial Mediterranean fever | true | false | 685 |
EC:00262 | UNII:37CQ2C7X93 | DB06168 | Canakinumab | MONDO:0009572 | autosomal recessive familial Mediterranean fever | true | false | 686 |
EC:00262 | UNII:37CQ2C7X93 | DB06168 | Canakinumab | MONDO:0007601 | familial Mediterranean fever, autosomal dominant | true | false | 687 |
EC:00262 | UNII:37CQ2C7X93 | DB06168 | Canakinumab | MONDO:0005393 | gout | true | false | 688 |
EC:00262 | UNII:37CQ2C7X93 | DB06168 | Canakinumab | MONDO:0017708 | mevalonate kinase deficiency | true | false | 690 |
EC:00262 | UNII:37CQ2C7X93 | DB06168 | Canakinumab | MONDO:0009849 | hyperimmunoglobulinemia D with periodic fever | true | false | 691 |
EC:00262 | UNII:37CQ2C7X93 | DB06168 | Canakinumab | MONDO:0019355 | adult-onset Still disease | true | false | 692 |
EC:00262 | UNII:37CQ2C7X93 | DB06168 | Canakinumab | MONDO:0019434 | systemic-onset juvenile idiopathic arthritis | true | false | 693 |
EC:00262 | UNII:37CQ2C7X93 | DB06168 | Canakinumab | MONDO:0007727 | autosomal dominant familial periodic fever | true | false | 694 |
EC:00263 | CHEBI:3347 | DB13919 | Candesartan | MONDO:0006993 | systolic heart failure | true | false | 695 |
EC:00263 | CHEBI:3347 | DB13919 | Candesartan | MONDO:0001134 | essential hypertension | true | false | 696 |
EC:00263 | CHEBI:3347 | DB13919 | Candesartan | MONDO:0005044 | hypertensive disorder | true | false | 698 |
EC:00263 | CHEBI:3347 | DB13919 | Candesartan | MONDO:0005277 | migraine disorder | false | true | 700 |
EC:00263 | CHEBI:3347 | DB13919 | Candesartan | MONDO:0005542 | acute coronary syndrome | false | true | 701 |
EC:00263 | CHEBI:3347 | DB13919 | Candesartan | MONDO:0005300 | chronic kidney disease | false | true | 703 |
EC:00263 | CHEBI:3347 | DB13919 | Candesartan | MONDO:0005016 | diabetic kidney disease | false | true | 711 |
EC:00263 | CHEBI:3347 | DB13919 | Candesartan | MONDO:0041656 | ST-elevation myocardial infarction | false | true | 712 |
EC:00265 | CHEBI:69478 | DB09061 | Cannabidiol | MONDO:0016532 | Lennox-Gastaut syndrome | true | false | 715 |
EC:00265 | CHEBI:69478 | DB09061 | Cannabidiol | MONDO:0100135 | Dravet syndrome | true | false | 716 |
EC:00265 | CHEBI:69478 | DB09061 | Cannabidiol | MONDO:0001734 | Tuberous Sclerosis | true | false | 717 |
EC:00266 | CHEBI:64213 | DB12328 | Cantharidin | MONDO:0005855 | molluscum contagiosum | true | false | 718 |
EC:00267 | CHEBI:31348 | DB01101 | Capecitabine | MONDO:0007254 | breast cancer | true | false | 719 |
EC:00267 | CHEBI:31348 | DB01101 | Capecitabine | MONDO:0005575 | colorectal cancer | true | false | 722 |
EC:00267 | CHEBI:31348 | DB01101 | Capecitabine | MONDO:0003219 | gastroesophageal junction adenocarcinoma | true | false | 723 |
EC:00267 | CHEBI:31348 | DB01101 | Capecitabine | MONDO:0009831 | malignant pancreatic neoplasm | true | false | 725 |
EC:00268 | CHEBI:229222 | DB12218 | Capivasertib | MONDO:0700079 | hormone receptor-positive breast cancer | true | false | 728 |
EC:00268 | CHEBI:229222 | DB12218 | Capivasertib | MONDO:0000618 | Her2-receptor negative breast cancer | true | false | 729 |
EC:00269 | UNII:2R27AB6766 | DB06081 | Caplacizumab | MONDO:0018896 | thrombotic thrombocytopenic purpura | true | false | 730 |
EC:00270 | CHEBI:231693 | DB11791 | Capmatinib | MONDO:0005233 | non-small cell lung carcinoma | true | false | 731 |
EC:00272 | CHEBI:3374 | DB06774 | Capsaicin | MONDO:0041052 | postherpetic neuralgia | true | false | 732 |
EC:00273 | CHEBI:3380 | DB01197 | Captopril | MONDO:0005542 | Acute coronary syndrome | true | false | 736 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.